RCM

RA Capital Management Portfolio holdings

AUM $8.12B
1-Year Est. Return 46.06%
This Quarter Est. Return
1 Year Est. Return
+46.06%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$6.4B
AUM Growth
+$1.32B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
71
New
Increased
Reduced
Closed

Top Buys

1
+$309M
2
+$35.7M
3
+$27.6M
4
URGN icon
UroGen Pharma
URGN
+$24M
5
GPCR icon
Structure Therapeutics
GPCR
+$19.8M

Top Sells

1
+$77.1M
2
+$62.6M
3
+$36.6M
4
RNA icon
Avidity Biosciences
RNA
+$35.9M
5
CVAC icon
CureVac
CVAC
+$33.1M

Sector Composition

1 Healthcare 99.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
51
$17.3M 0.27%
+421,348
52
$17.1M 0.27%
+1,500,000
53
$14.5M 0.23%
800,000
54
$11.6M 0.18%
2,744,270
-7,860,074
55
$11.3M 0.18%
1,286,000
56
$9.91M 0.15%
3,525,754
57
$8.47M 0.13%
8,800,000
+2,298,376
58
$7.79M 0.12%
937,500
59
$3.61M 0.06%
3,062,871
-3,928,132
60
$3.01M 0.05%
347,069
61
$1.63M 0.03%
+237,408
62
$1.04M 0.02%
333,333
63
– –
-4,398,453
64
– –
-1,400,001
65
– –
-6,416,147
66
– –
-3,370,506
67
– –
-1,246,667
68
– –
-1,239,000
69
– –
-240,324
70
– –
-2,007,946
71
– –
-1,723,373
1 2
3